LSE:SN 6 November 2025 - 1 February 2026

Smith & Nephew closed Friday up 2.35% at 1,242 pence, beating the broader London market. Fitch assigned the company a BBB+ rating with a stable outlook on Jan. 30. Investors await the Bank of England’s Feb. 5 decision and Smith & Nephew’s earnings on March 2.

Smith & Nephew shares fell 0.8% to 1,225.5p on Friday, valuing the company at about £10.4 billion. CEO Deepak Nath and three executives bought U.S.-listed depositary shares on Jan. 16, a filing showed. The company finalized its $450 million acquisition of Integrity Orthopaedics on Jan. 21. Investors await full-year results and guidance on March 2.

Smith & Nephew shares closed down 0.9% at 1,258p in London on Friday. CEO Deepak Nath will speak at the J.P. Morgan Healthcare Conference on Jan. 12, with investors awaiting details on 2026 targets and orthopaedics performance. Full-year results are due March 2.